Innovenn
Mary E. Dixon is an accomplished executive with extensive experience in the pharmaceutical and medical device industries. As the CEO and Founder of Innovenn, Inc. since April 2013, Mary leads the development of AI-enhanced medical device software, while also serving as CEO and Founder of Improvita since May 2019, focusing on Human Factors, Usability Engineering, and User Experience consulting. Additionally, Mary is the Owner of Innovenn Life Sciences, a consulting firm dedicated to providing expert resources for drug and device development across various clinical research areas. Other notable roles include a consultant in clinical development for several pharmaceutical companies and organizer of WI Pharma Founders, a professional organization aimed at enhancing industry visibility in Wisconsin. Mary’s educational background includes studies at Seattle University, and prior positions include significant leadership roles in clinical development at both large and small pharmaceutical companies.
This person is not in any teams
Innovenn
1 followers
Innovenn, established in 2014, helps develop patient-centered health innovations to improve health through enabling data driven Precision Medicine. With years of experience in drug and device development utilizing a structured risk-based lifecycle process, the Innovenn team will help manage successful product development projects enabling regulatory approvals, product adoption and market success for patient-centric health innovations. We offer a powerful combination of skills and capabilities to leverage process, scientific rigor, and data to design and launch patient-centered health innovations that enable Precision Medicine, target unmet needs, and improve patient health.